Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
61.14
+1.26 (2.10%)
Sep 2, 2026, 2:00 PM EDT - Market open
Ionis Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 874.09 | 943.71 | 705.14 | 787.65 | 587.37 | 810.46 |
Revenue Growth | -7.41% | 33.83% | -10.47% | 34.10% | -27.53% | 11.13% |
Gross Profit Gross Profit Growth | -60.6 | 12.18 | -207.61 | -121.11 | -259.9 | 156.16 |
Operating Income Operating Income Growth | -594.35 | -381.68 | -475.08 | -353.73 | -410.19 | -30.19 |
Net Income Net Income Growth | -565.17 | -381.39 | -453.9 | -366.29 | -269.72 | -28.6 |
Earnings Per Share EPS Growth | -3.46 | -2.38 | -3.04 | -2.56 | -1.90 | -0.20 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
TRYNGOLZA TRYNGOLZA Growth | 113.6 | 107.5 | - | - | - | - |
DAWNZERA DAWNZERA Growth | - | 7.8 | - | - | - | - |
SPINRAZA Royalties SPINRAZA Royalties Growth | 207.2 | 212.3 | 216.1 | 240.4 | 242.3 | 267.8 |
WAINUA Royalties WAINUA Royalties Growth | 56.4 | 49.1 | 20.2 | - | - | - |
Other Commercial Other Commercial Growth | 34.1 | 35 | 35.8 | 34.9 | 30.1 | 55.5 |
Other Royalties Other Royalties Growth | 22.1 | 24.1 | 21 | 33.3 | 31 | 19.1 |
Amortization from Upfront Payments Amortization from Upfront Payments Growth | - | - | 131.4 | 125.3 | 68.6 | 77.5 |
Milestone Payments Milestone Payments Growth | - | - | 106.4 | 100.5 | 74 | 88.3 |
R&D License Fees R&D License Fees Growth | - | - | 71.3 | 116.8 | 37 | 291.3 |
Other R&D Services Other R&D Services Growth | - | - | 23.5 | 10 | 27.6 | 11 |
WAINUA Joint Development WAINUA Joint Development Growth | 53.1 | 42.1 | 79.4 | 126.4 | 76.8 | - |
Revenue (Total) Revenue (Total) Growth | 874.09 | 943.71 | 705.14 | 787.65 | 587.37 | 810.46 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,102 | 2,680 | 2,303 | 2,338 | 1,997 | 2,133 |
Total Debt Total Debt Growth | 2,189 | 2,616 | 1,959 | 1,967 | 1,369 | 1,251 |
Net Cash (Debt) Net Cash Growth | -86.67 | 64.58 | 344.14 | 370.23 | 628.21 | 882.13 |
Net Cash Growth | - | -81.23% | -7.05% | -41.07% | -28.78% | -8.06% |
Net Cash Per Share Net Cash Per Share Growth | -0.53 | 0.40 | 2.30 | 2.59 | 4.43 | 6.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -496.43 | -268.58 | -500.95 | -307.51 | -274.37 | 30.8 |
Capital Expenditures CapEx Growth | -64.41 | -51.44 | -45.28 | -23.81 | -15.72 | -11.96 |
Free Cash Flow Free Cash Flow Growth | -560.84 | -320.03 | -546.23 | -331.32 | -290.09 | 18.84 |
Free Cash Flow Growth | - | - | - | - | - | 2340.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -6.93% | 1.29% | -29.44% | -15.38% | -44.25% | 19.27% |
Operating Margin | -68.00% | -40.45% | -67.37% | -44.91% | -69.84% | -3.72% |
Pretax Margin | -64.30% | -40.22% | -65.25% | -42.40% | -43.92% | -3.60% |
Profit Margin | -64.66% | -40.41% | -64.37% | -46.50% | -45.92% | -3.53% |
FCF Margin | -64.16% | -33.91% | -77.46% | -42.06% | -49.39% | 2.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 216.04 | 216.04 | 216.04 | 216.04 | 216.04 |
P/FCF Ratio | - | - | - | - | - | 228.03 |
PS Ratio | 11.38 | 13.58 | 7.83 | 9.22 | 9.13 | 5.30 |